Targeting the ATP Synthase in
ATP synthase
Candida albicans
DCCD
SCV
Staphylococcus aureus
Streptococcus pyogenes
oligomycin A
resveratrol
small colony variants
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
02 Apr 2021
02 Apr 2021
Historique:
received:
26
02
2021
revised:
25
03
2021
accepted:
31
03
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
The ATP synthase has been validated as a druggable target with the approval of the ATP synthase inhibitor, bedaquiline, for treatment of drug-resistant
Identifiants
pubmed: 33918382
pii: antibiotics10040376
doi: 10.3390/antibiotics10040376
pmc: PMC8067178
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Novo Nordisk Fonden
ID : NNF20OC0062531
Références
J Bioenerg Biomembr. 1992 Oct;24(5):485-91
pubmed: 1331039
BMC Pharmacol Toxicol. 2018 Feb 13;19(1):7
pubmed: 29439722
Nat Rev Drug Discov. 2013 May;12(5):371-87
pubmed: 23629505
BMC Microbiol. 2020 Oct 12;20(1):306
pubmed: 33045992
Antimicrob Agents Chemother. 1980 Nov;18(5):722-9
pubmed: 7447428
Int J Biol Macromol. 2009 Jul 1;45(1):72-9
pubmed: 19375450
Sci Rep. 2020 May 18;10(1):8134
pubmed: 32424122
J Med Chem. 2019 Mar 14;62(5):2305-2332
pubmed: 30779564
Antimicrob Agents Chemother. 2009 Mar;53(3):1290-2
pubmed: 19075053
Int J Antimicrob Agents. 2019 Jun;53(6):716-723
pubmed: 30825504
Mol Microbiol. 2003 Apr;48(1):77-84
pubmed: 12657046
Antimicrob Agents Chemother. 2011 May;55(5):1937-45
pubmed: 21357296
Clin Microbiol Rev. 2016 Apr;29(2):401-27
pubmed: 26960941
Curr Opin Struct Biol. 2018 Oct;52:71-79
pubmed: 30240940
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Sci Rep. 2015 May 21;5:9838
pubmed: 25996237
J Antibiot (Tokyo). 2017 Jul;70(8):871-877
pubmed: 28420869
Medicines (Basel). 2017 May 01;4(2):
pubmed: 28930240
Biochim Biophys Acta. 2015 Sep;1847(9):849-60
pubmed: 25667968
Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13632-7
pubmed: 17698806
mBio. 2013 Feb 12;4(1):e00537-12
pubmed: 23404398
Front Microbiol. 2016 Dec 19;7:2018
pubmed: 28066345
Int J Infect Dis. 2017 Jan;54:77-84
pubmed: 27915108
Sci Rep. 2020 Jul 9;10(1):11391
pubmed: 32647350
Antimicrob Agents Chemother. 2012 Aug;56(8):4131-9
pubmed: 22615276
Microbiol Mol Biol Rev. 2008 Dec;72(4):590-641, Table of Contents
pubmed: 19052322
FEMS Microbiol Lett. 2002 Jun 18;212(1):133-8
pubmed: 12076799
Int J Antimicrob Agents. 2018 Sep;52(3):390-396
pubmed: 29906565
Am J Health Syst Pharm. 2013 Nov 15;70(22):1984-94
pubmed: 24173008
Front Microbiol. 2018 Aug 07;9:1808
pubmed: 30131787
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29610201
J Antimicrob Chemother. 2012 Mar;67(3):559-68
pubmed: 22129590
Antibiot Chemother (Northfield). 1954 Sep;4(9):962-70
pubmed: 24543225
Mol Cells. 2005 Jun 30;19(3):365-74
pubmed: 15995353
Sci Rep. 2011;1:125
pubmed: 22355642
J Bacteriol. 2005 Jul;187(14):5023-8
pubmed: 15995221
mBio. 2017 Sep 5;8(5):
pubmed: 28874470
FEBS Lett. 2001 Apr 6;494(1-2):1-5
pubmed: 11297723
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):13961-5
pubmed: 22869738
PLoS Pathog. 2018 Mar 19;14(3):e1006907
pubmed: 29554137